Novel Prognostic Models for Patients With Penile Carcinoma.


Journal

Cancer control : journal of the Moffitt Cancer Center
ISSN: 1526-2359
Titre abrégé: Cancer Control
Pays: United States
ID NLM: 9438457

Informations de publication

Date de publication:
Historique:
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 29 12 2020
Statut: ppublish

Résumé

Although penile carcinoma is a rare malignancy, there is still an unmet need to identify prognostic factors associated with poor survival. In this study, we utilized demographic and clinical information to identify the most informative variables associated with overall survival in patients with penile cancer. From a full model including all covariates found to be statistically significant in univariable analyses, we identified a parsimonious reduced model containing tumor site (penis glans: hazard ratio [HR] = 0.48; 95% CI: 0.28-0.85 and penis not otherwise specified: HR = 0.45; 95% CI: 0.25-0.84), undetermined tumor differentiation (HR = 0.48; 95% CI: 0.27-0.86), and TNM stage III/IV (HR = 2.83; 95% CI: 1.68-4.75). When all of the covariates from the full model were subjected to classification and regression tree analysis, we identified 6 novel risk groups. Of particular interest, we found marriage was associated with substantial improvement in survival among men with the same stage and disease site. Specifically, among single/widowed/divorced men with TNM stage 0-II and prepuce/penis corpus/overlapping lesions had worse survival (5-year survival = 18.2%) versus married men (5-year survival = 62.5%). Since marital status is linked to social support, these findings warrant a deeper investigation into the relationships between disease prognosis and social support in patients with penile carcinoma.

Identifiants

pubmed: 32397742
doi: 10.1177/1073274820924728
pmc: PMC7223867
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073274820924728

Subventions

Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA147832
Pays : United States

Références

BJU Int. 2017 Feb;119(2):254-260
pubmed: 27373878
J Urol. 1996 Nov;156(5):1637-42
pubmed: 8863559
Clin Genitourin Cancer. 2017 Oct;15(5):605-609
pubmed: 28499559
J Cancer. 2019 Jun 2;10(12):2661-2669
pubmed: 31258774
Clin Genitourin Cancer. 2014 Apr;12(2):138-42
pubmed: 24210829
Urology. 2018 Mar;113:254
pubmed: 29174621
Cancer Causes Control. 2013 Jan;24(1):71-9
pubmed: 23109172
Biosci Rep. 2018 Oct 31;38(5):
pubmed: 30279203
Urol Oncol. 2016 Mar;34(3):122.e9-15
pubmed: 26547834
Eur Urol Focus. 2019 Sep;5(5):713-717
pubmed: 31288989
Cancer. 2008 Nov 15;113(10 Suppl):2883-91
pubmed: 18980292
Ann Behav Med. 2003 Dec;26(3):172-81
pubmed: 14644693
J Magn Reson Imaging. 2020 Jun;51(6):1612-1629
pubmed: 31976600
Oncology (Williston Park). 2016 Mar;30(3):245-9
pubmed: 26984219
Int J Cancer. 2013 Sep 1;133(5):1173-9
pubmed: 23404289
Urol Oncol. 2018 Jan;36(1):14.e17-14.e24
pubmed: 29031418
Urol Int. 2014;92(2):194-201
pubmed: 24051343
BMC Cancer. 2019 May 21;19(1):476
pubmed: 31113402
Sex Transm Infect. 2015 Feb;91(1):61-7
pubmed: 25278617
Maedica (Buchar). 2011 Oct;6(4):313-20
pubmed: 22879847
Cancer Manag Res. 2019 Jul 10;11:6425-6441
pubmed: 31372046
Alcohol Health Res World. 1997;21(1):30-41
pubmed: 15706761
J Surg Oncol. 2006 Feb 1;93(2):133-8
pubmed: 16425300
Am J Pathol. 2001 Oct;159(4):1211-8
pubmed: 11583947
J Prev Med Public Health. 2015 Jan;48(1):1-9
pubmed: 25652705
Cancer. 2004 Sep 15;101(6):1357-63
pubmed: 15316902
J Natl Compr Canc Netw. 2013 May 1;11(5):617-24
pubmed: 23667210
Am Fam Physician. 2010 Jan 15;81(2):167-74
pubmed: 20082512
Eur J Oncol Nurs. 2013 Oct;17(5):661-7
pubmed: 23896180
Nat Clin Pract Urol. 2007 Mar;4(3):140-6
pubmed: 17347658
J Natl Cancer Inst. 1995 Nov 15;87(22):1705-9
pubmed: 7473819

Auteurs

Monica E Reyes (ME)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Heloise Borges (H)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Muhamed Said Adjao (MS)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Nisha Vijayakumar (N)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Philippe E Spiess (PE)

Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Matthew B Schabath (MB)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH